Arthur Nagal

Title: Arthur Nagal: Innovator in Heterocyclic Compounds

Introduction

Arthur Nagal is a notable inventor based in Gales Ferry, CT (US). He has made significant contributions to the field of pharmacology, particularly through his work on heterocyclic compounds. With a total of 2 patents, Nagal's innovations have the potential to impact therapeutic approaches in neuroscience.

Latest Patents

Nagal's latest patents focus on heterocyclic compounds as ligands of the GABAA receptor. These patents disclose compounds that are highly selective agonists, antagonists, or inverse agonists for GABA brain receptors. The compounds are defined by specific variables, and they include pharmaceutically acceptable salts. This work is crucial as it explores new avenues for drug development targeting GABA brain receptors.

Career Highlights

Throughout his career, Arthur Nagal has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Neurogen Corporation and Pfizer Corporation. His experience in these organizations has allowed him to contribute to significant advancements in drug discovery and development.

Collaborations

Nagal has collaborated with several professionals in his field, including Daniel Yohannes and George D. Maynard. These collaborations have likely enriched his research and contributed to the success of his innovations.

Conclusion

Arthur Nagal's work in developing heterocyclic compounds as ligands for GABAA receptors showcases his innovative spirit and dedication to advancing pharmacological science. His contributions are poised to influence future therapeutic strategies in treating neurological disorders.